Evidence map›Paper›PMID 26820972›Full record

ArticleCytotechnology2016

Generation and characterization of human cardiac resident and non-resident mesenchymal stem cell.

Baskar Subramani, Sellamuthu Subbannagounder, Sekar Palanivel, Chithra Ramanathanpullai, Sivakumar Sivalingam, Azhari Yakub, Manjunath SadanandaRao, Arivudainambi Seenichamy, Ashok Kumar Pandurangan, Jun Jie Tan and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cytotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. The application of umbilical cord-derived MSCs in cardiovascular diseases.Journal of cellular and molecular medicine · 2021
    Review
  2. Article
  3. Article
  4. Review
  5. Cardiac NestinMolecular therapy : the journal of the American Society of Gene Therapy · 2020
    Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Baskar SubramaniNichi-Asia Life Sdn Bhd., 47810, Petaling Jaya, Selangor, Malaysia.
Sellamuthu SubbannagounderNichi-Asia Life Sdn Bhd., 47810, Petaling Jaya, Selangor, Malaysia.
Sekar PalanivelDepartments of Zoology, Government Arts College (Autonomous), Salem, 636007, Tamil Nadu, India.
Chithra RamanathanpullaiNichi-Asia Life Sdn Bhd., 47810, Petaling Jaya, Selangor, Malaysia.
Sivakumar SivalingamCardiothoracic Surgery Unit, National Heart Institute, 50400, Kuala Lumpur, Malaysia.
Azhari YakubCardiothoracic Surgery Unit, National Heart Institute, 50400, Kuala Lumpur, Malaysia.
Manjunath SadanandaRaoMicro Therapeutic Research Labs Pvt. Ltd, Chennai, Tamil Nadu, India.
Arivudainambi SeenichamyDepartment of Veterinary Pathology and Microbiology, Universiti Putra Malaysia, Serdang, Malaysia.
Ashok Kumar PanduranganDepartment of Pharmacology, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.
Jun Jie TanRegeneration Medicine Cluster, Advanced Medicine and Dental Institute, Universiti Sains Malaysia, George Town, Pulau Pinang, Malaysia.
Rajesh RamasamyStem Cell and Immunity Group, Immunology Laboratory Unit, Department Of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia. rajesh@upm.edu.my.
National Heart Institute · MYUniversiti Putra Malaysia · MYBharathiar University · INMicro Labs (India) · INUniversiti Sains Malaysia · MYUniversity of Malaya · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the surgical and other insertional interventions, the complete recuperation of myocardial disorders is still elusive due to the insufficiency of functioning myocardiocytes. Thus, the use of stem cells to regenerate the affected region of heart becomes a prime important. In line with this human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) have gained considerable interest due to their potential use for mesodermal cell based replacement therapy and tissue engineering. Since MSCs are harvested from various organs and anatomical locations of same organism, thus the cardiac regenerative potential of human cardiac-derived MSCs (hC-MSCs) and human umbilical cord Wharton's Jelly derived MSC (hUC-MSCs) were tested concurrently. At in vitro culture, both hUC-MSCs and hC-MSCs assumed spindle shape morphology with expression of typical MSC markers namely CD105, CD73, CD90 and CD44. Although, hUC-MSCs and hC-MSCs are identical in term of morphology and immunophenotype, yet hUC-MSCs harbored a higher cell growth as compared to the hC-MSCs. The inherent cardiac regenerative potential of both cells were further investigated with mRNA expression of ion channels. The RT-PCR results demonstrated that both MSCs were expressing a notable level of delayed rectifier-like K(+) current (I KDR ) ion channel, yet the relative expression level was considerably varied between hUC-MSCs and hC-MSCs that Kv1.1(39 ± 0.6 vs 31 ± 0.8), Kv2.1 (6 ± 0.2 vs 21 ± 0.12), Kv1.5 (7.4 ± 0.1 vs 6.8 ± 0.06) and Kv7.3 (27 ± 0.8 vs 13.8 ± 0.6). Similarly, the Ca2(+)-activated K(+) current (I KCa ) channel encoding gene, transient outward K(+) current (I to ) and TTX-sensitive transient inward sodium current (I Na.TTX ) encoding gene (Kv4.2, Kv4.3 and hNE-Na) expressions were detected in both groups as well. Despite the morphological and phenotypical similarity, the present study also confirms the existence of multiple functional ion channel currents IKDR, IKCa, Ito, and INa.TTX in undifferentiated hUC-MSCs as of hC-MSCs. Thus, the hUC-MSCs can be exploited as a potential candidate for future cardiac regeneration.

Indexed as

Cardiac resident stem cell and umbilical cord stem cellElectrophysiologyMesenchymal stem cell

Identifiers

PMID26820972
PMCPMC5023579
OpenAlexW2268354639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.